| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.29 | 0.05 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |